Europe Insulin Delivery Devices Market Size- By Type, By Application, By Distribution Channel, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Europe Insulin Delivery Devices Market Introduction and Overview

According to SPER market research, 'Europe Insulin Delivery Devices Market Size - By Type, By Application, By Distribution Channel, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Europe Insulin Delivery Devices Market is predicted to reach USD 3.54 billion by 2033 with CAGR of 3.19%.

Insulin is essentially an essential component of every patient's treatment regimen for both Type 1 and Type 2 diabetes. Insulin pens, syringes, insulin pumps, and jet injectors are used to inject the insulin delivery device directly into the fatty tissues beneath the skin. Newer insulin delivery devices have been developed in response to the growing demand for minimally invasive delivery systems, particularly in underserved geographic areas of the world.

Significantly, the market for insulin delivery devices was affected by the COVID-19 epidemic. COVID-19 has an increased influence on persons with type 1 diabetes. Immune systems that are already compromised in diabetics become much more compromised when exposed to COVID-19. Compared to healthy individuals, diabetics may be more likely to experience major complications.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Type, By Application, By Distribution Channel, By End Use

Regions covered Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe

Companies Covered Medtronic, F Hoffmann-La Roche Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Sanofi, Johnson & Johnson Private Limited ., Abbott, Terumo Corporation, AstraZeneca, B. Braun Melsungen AG, Julphar, Eli Lily and Company, Biocon, WOCKHARDT and various others.

Europe Insulin Delivery Devices Market Segmentation:

By Type: Based on the Type, Europe Insulin Delivery Devices Market is segmented as; Insulin Syringes, Insulin Jet Injectors, Pen Needles, Insulin Pumps.

By Application: Based on the Application, Europe Insulin Delivery Devices Market is segmented as; Type I Diabetes, Type II Diabetes.

By Distribution Channel: Based on the Distribution Channel, Europe Insulin Delivery Devices Market is segmented as; Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics.

Product Code: HLCA2418

1.Introduction

1.1.Scope of the report
1.2.Market segment analysis

2.Research Methodology

2.1.Research data source
2.1.1.Secondary Data
2.1.2.Primary Data
2.1.3.SPER's internal database
2.1.4.Premium insight from KOL's
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.1.4.Challenges
4.2.COVID-19 Impacts of the Europe Insulin Delivery Devices Market

5.Market variable and outlook

5.1.SWOT Analysis
5.1.1.Strengths
5.1.2.Weaknesses
5.1.3.Opportunities
5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape
5.2.2.Economic Landscape
5.2.3.Social Landscape
5.2.4.Technological Landscape
5.2.5.Environmental Landscape
5.2.6.Legal Landscape
5.3.PORTER's Five Forces
5.3.1.Bargaining power of suppliers
5.3.2.Bargaining power of buyers
5.3.3.Threat of Substitute
5.3.4.Threat of new entrant
5.3.5.Competitive rivalry
5.4.Heat Map Analysis

6.Competitive Landscape

6.1. Europe Insulin Delivery Devices Market Manufacturing Base Distribution, Sales Area, Application Type
6.2.Mergers & Acquisitions, Partnerships, Type Launch, and Collaboration in Europe Insulin Delivery Devices Market

7. Europe Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)

7.1. Europe Insulin Delivery Devices Market Value Share and Forecast, By Type, 2023-2033
7.2.Insulin Jet Injectors
7.3.Insulin Pumps
7.4.Insulin Syringes
7.5.Pen Needles

8.Europe Insulin Delivery Devices Market, By Application, 2019-2033 (USD Million)

8.1. Europe Insulin Delivery Devices Market Value Share and Forecast, By Application, 2023-2033
8.2.Type I Diabetes
8.3.Type II Diabetes

9.Europe Insulin Delivery Devices Market, By Distribution Channel, 2019-2033 (USD Million)

9.1. Europe Insulin Delivery Devices Market Value Share and Forecast, By Distribution Channel, 2023-2033
9.2.Diabetes Clinics
9.3.Hospital Pharmacy
9.4.Online Sales
9.5.Retail Pharmacy

10.Europe Insulin Delivery Devices Market, By End Use, 2019-2033 (USD Million)

10.1. Europe Insulin Delivery Devices Market Value Share and Forecast, By End Use, 2023-2033
10.2.Clinics
10.3.Homecare
10.4.Hospitals
10.5.Specialty Centres

11. Europe Insulin Delivery Devices Market Forecast, 2019-2033 (USD Million)

11.1. Europe Insulin Delivery Devices Market Size and Market Share

12.Europe Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)

12.1. Europe Insulin Delivery Devices Market Size and Market Share By Type (2019-2026)
12.2. Europe Insulin Delivery Devices Market Size and Market Share By Type (2027-2033)

13.Europe Insulin Delivery Devices Market, By Application, 2019-2033 (USD Million)

13.1. Europe Insulin Delivery Devices Market Size and Market Share By Application (2019-2026)
13.2. Europe Insulin Delivery Devices Market Size and Market Share By Application (2027-2033)

14. Europe Insulin Delivery Devices Market, By Distribution Channel, 2019-2033 (USD Million)

14.1. Europe Insulin Delivery Devices Market Size and Market Share By Distribution Channel (2019-2026)
14.2. Europe Insulin Delivery Devices Market Size and Market Share By Distribution Channel (2027-2033)

15.Europe Insulin Delivery Devices Market, By End Use, 2019-2033 (USD Million)

15.1. Europe Insulin Delivery Devices Market Size and Market Share By End Use (2019-2026)
15.2. Europe Insulin Delivery Devices Market Size and Market Share By End Use (2027-2033)

16. Europe Insulin Delivery Devices Market, By Region, 2019-2033 (USD Million)

16.1. Europe Insulin Delivery Devices Market Size and Market Share By Region (2019-2026)
16.2. Europe Insulin Delivery Devices Market Size and Market Share By Region (2027-2033)
16.2.1.Belgium
16.2.2.France
16.2.3.Germany
16.2.4.Italy
16.2.5.Netherland
16.2.6.Russia
16.2.7.Spain
16.2.8.Switzerland
16.2.9.Turkey
16.2.10.U.K.
16.2.11.Rest of Europe

17.Company Profile

17.1.Abbott
17.1.1.Company details
17.1.2.Financial outlook
17.1.3.Type summary
17.1.4.Recent developments
17.2.Biocon
17.2.1.Company details
17.2.2.Financial outlook
17.2.3.Type summary
17.2.4.Recent developments
17.3.Eli Lily and Company
17.3.1.Company details
17.3.2.Financial outlook
17.3.3.Type summary
17.3.4.Recent developments
17.4.Johnson & Johnson Private Limited
17.4.1.Company details
17.4.2.Financial outlook
17.4.3.Type summary
17.4.4.Recent developments
17.5.Medtronic
17.5.1.Company details
17.5.2.Financial outlook
17.5.3.Type summary
17.5.4.Recent developments
17.6.Tandem Diabetes Care Inc.
17.6.1.Company details
17.6.2.Financial outlook
17.6.3.Type summary
17.6.4.Recent developments
17.7.Others

15List of Abbreviations

16Reference Links

17Conclusion

18Research Scope